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Purpose: To develop a comprehensive peripheral dose (PD) dataset for the two unflattened beams of
nominal energy 6 and 10 MV for use in clinical care.
Methods: Measurements were made in a 40×120×20 cm3 (width × length × depth) stack of solid
water using an ionization chamber at varying depths (dmax, 5, and 10 cm), field sizes (3×3 to
30×30 cm2), and distances from the field edge (5–40 cm). The effects of the multileaf collimator
(MLC) and collimator rotation were also evaluated for a 10×10 cm2 field. Using the same phantom
geometry, the accuracy of the analytic anisotropic algorithm (AAA) and Acuros dose calculation
algorithm was assessed and compared to the measured values.
Results: The PDs for both the 6 flattening filter free (FFF) and 10 FFF photon beams were found
to decrease with increasing distance from the radiation field edge and the decreasing field size. The
measured PD was observed to be higher for the 6 FFF than for the 10 FFF for all field sizes and depths.
The impact of collimator rotation was not found to be clinically significant when used in conjunction
with MLCs. AAA and Acuros algorithms both underestimated the PD with average errors of −13.6%
and −7.8%, respectively, for all field sizes and depths at distances of 5 and 10 cm from the field edge,
but the average error was found to increase to nearly −69% at greater distances.
Conclusions: Given the known inaccuracies of peripheral dose calculations, this comprehensive
dataset can be used to estimate the out-of-field dose to regions of interest such as organs at risk,
electronic implantable devices, and a fetus. While the impact of collimator rotation was not found to
significantly decrease PD when used in conjunction with MLCs, results are expected to be machine
model and beam energy dependent. It is not recommended to use a treatment planning system to
estimate PD due to the underestimation of the out-of-field dose and the inability to calculate dose at
extended distances due to the limits of the dose calculation matrix. C 2016 American Association of
Physicists in Medicine. [http://dx.doi.org/10.1118/1.4958963]
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1. INTRODUCTION
As the clinical use of the flattening filter free (FFF) photon
beams increases in radiation therapy, the need for in-depth
characterizations of FFF beams has arisen due to inherent
differences in beam properties from the conventional flattened
beams. The reported benefits of unflattened compared to
flattened photon beams include an increase in dose rate,
reduced scatter and leakage radiation, and a reduction in
peripheral dose (PD).1–11 Peripheral or out-of-field dose is
defined as the absorbed dose outside of the radiation treatment
field borders.12,13 Peripheral dose is due to contributions
from leakage radiation from the head of the treatment
unit, scatter radiation from the collimator head and beam
modifiers, and internal scatter within the patient.14–16 The PD
may be clinically significant when dose to the fetus or to
organs with low dose tolerances (e.g. gonads, lens of eye)
must be minimized. Peripheral doses are also relevant when
considering the risk of secondary malignancies or the potential
failure of the implanted electronic devices (e.g., pacemakers,
defibrillators).5,12,15,17–19
Numerous studies have investigated the trends in PD
for flattened photon beams with varying field sizes, depth,
and distances from the field edge, as well as the effects
of beam modifiers [e.g., multileaf collimators (MLCs)] and
collimator rotation.12,14–16,20–24 The removal of the flattening
filter changes the profile and dosimetric characteristics
of photon beams.3 As such, one cannot assume that
the PD trends observed with flattened beams will be
consistent with unflattened beams. Due to known inaccuracies
of PD calculations with commercial treatment planning
systems (TPSs),18,25 the typical means of assessing PD
are through phantom measurements or Monte Carlo (MC)
simulations.4,6
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Several MC publications2,5,7,9 have investigated the PD of
unflattened photon beams compared to flattened beams, both
in the scenario in which the incident electron energy of the
flattened and unflattened beams is matched (i.e., similar to
the model utilized by Varian Medical Systems10), and when
the incident energy of the unflattened beam is increased to
match the attenuation of the corresponding flattened beam
(i.e., similar to the model employed by Elekta10). The ma-
jority of these publications2,7,9 have suggested that the PDs
of unflattened beams are lower than the corresponding PDs
for flattened beams, and that this difference increases with
photon energy and decreasing field size. Additionally, Alm-
berg et al.7 simulated both 6 FFF scenarios (incident electron
energies of 6.45 and 8 MeV), and reported that the PD reduc-
tion was enhanced by increasing the incident photon energy
(i.e., 8 MeV), suggesting that PD is not only dependent on
the machine design but also on the implementation of the FFF
technology. In contrast to previously published MC simula-
tions, Kry et al.5 reported that the difference in PD between
flattened and unflattened photon beams is dependent on the
distance from the field edge. Within the first 3 cm of the field,
they observed that the PD of the FFF beam was lower than
the corresponding flattened beam. At distances between 3 and
15 cm from the field edge, the PD was typically higher in FFF
mode, and beyond 15 cm, the PD was again lower in FFF
mode.
Also, PD of FFF beams has been studied for the treat-
ment plans generated for the intensity modulated radiation
therapy (IMRT), stereotactic body radiotherapy (SBRT), and
stereotactic radiosurgery (SRS)4,8 as well as for square and
rectangular open fields.7,11,19 Similar to the MC studies, these
publications have suggested that the PD of unflattened beams
is lower than flattened beams of the same nominal energy and
that the relative difference in PD increases with energy.
The intention of the current study was to develop a
comprehensive PD dataset for 6 FFF and 10 FFF photon
beams that could be used for scenarios where the PD may
be clinically relevant. We also compared the trends in PD
measurements between the two unflattened beams, as well
as compared the PD of the 6 FFF beam with the published
results of a 6 MV flattened beam.26
2. METHODS
All measurements were performed for the 6 and 10 MV
unflattened photon beams of a Varian TrueBeam linac
(Varian Medical Systems, Palo Alto, CA) running version 1.6
of the control software and equipped with the Millennium
120-leaf MLCs. The PD of the two unflattened beams was
determined with a 40×120×20 cm3 (width × length × depth)
stack of solid water (Solid Water model 457, Gammex/RMI,
Milwaukee, WI) with an Exradin A12 ionization chamber
(Standard Imaging, Middleton, WI) inserted in a 2 cm slab
of solid water when positioned on the treatment couch
(see Fig. 1). Measurements were acquired at various depths
[nominal depth of maximum dose, dmax (1.5 cm for the 6
FFF beam and 2.0 cm for the 10 FFF beam), 5, and 10 cm],
field sizes (3× 3, 6× 6, 10× 10, 15× 15, 20× 20, 25× 25,
and 30× 30 cm2), and distances (5, 10, 15, 20, 30, and
40 cm) between the field edge and the center of the ionization
chamber. The field aperture was shaped by matching the
MLCs and the jaws, and a 90◦ collimator rotation was used.
The distance from the field edge was defined at the surface of
the solid water phantom where the source-to-surface distance
was 100 cm (see Fig. 1). Peripheral dose measurements were
normalized to the measured central axis (CAX) dose at the
nominal dmax for a given field size. Additionally, the effects
of the tertiary MLC and collimator rotation were evaluated
for a 10×10 cm2 field size by acquiring PD measurements
with the collimator positioned at both 0◦ and 90◦ for the field
aperture set with the collimator jaw and/or MLCs.
To compare the measured PD with the dose calculated in the
TPS, a phantom with the same dimensions as the measurement
phantom was generated in  (version 10, Varian Medical
Systems, Palo Alto, CA). Beam models for the 6 FFF and 10
FFF were developed using the Varian TrueBeam representative
dataset which was based on the average of three machines.27 A
series of treatment plans were created using a single anterior
beam corresponding to each of the measured, static field sizes
with a 90◦ collimator rotation. To calculate the PDs, reference
points were added at the same depths and distances from the
field sizes that were measured. The PDs were calculated using
both the analytic anisotropic algorithm (AAA) version 10.0.42
F. 1. Schematic of the 40×120×20 cm3 (width × length × depth) solid water phantom used for the PD measurements. The distances from the field edge were
defined at a 100 cm source-to-surface distance (SSD). The schematic shows the three depths (nominal depth of maximum dose, dmax, 5, and 10 cm) at which
the ionization chamber was positioned in the solid water, for example, a 30 cm distance from the field edge.
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and the Acuros XB (AXB) algorithm version 10.0.42 with a
0.25 cm grid size. The calculated PD was normalized to CAX
at a depth of dmax to compare the normalized PD of both AAA
and Acuros to the measured data.
3. RESULTS
The trends in the measured PDs for the 6 FFF and 10 FFF
photon beams are shown in Fig. 2. The PD for all field sizes
(3×3 to 30×30 cm2) and distances (5–40 cm) are shown in
Table I for the 6 FFF beam and Table II for the 10 FFF beam.
F. 2. Measured PDs normalized to the CAX dose at a depth of nominal
dmax for the 6 FFF (solid line) and 10 FFF (dashed line) beams. The PD
measurements are shown at a depth of (A) nominal dmax (1.5 cm for the 6
FFF beam and 2.0 cm for the 10 FFF beam), (B) 5 cm, and (C) 10 cm and
were acquired for field sizes ranging from 3×3 to 30×30 cm2, and distances
of 5–40 cm from the field edge with the MLC shaping the field apertures and
with a collimator rotation of 90◦.
The measured PD at the nominal depth of dmax and at a
distance of 5 cm from the field edge for a 6×6 cm2 square
field was 0.51% and 0.48% for the 6 FFF and 10 FFF photon
beams, respectively. This compares to the measured PD for
a 30× 30 cm2 field at the same depth and distance from
the field edge of 2.01% and 1.63% for the 6 FFF and 10
FFF photon beams, respectively. The measured PD for the
6×6 cm2 square field at a distance of 5 cm from the field edge
was found to increase from 0.51% to 0.98% and 0.48% to
0.71% when the depth was varied between dmax and 10 cm,
for the 6 FFF and 10 FFF photon beams, respectively.
The effect of a 0◦ versus 90◦ collimator rotation, as well
as the impact of a tertiary MLC was also investigated for
a 10× 10 cm2 field size. The difference in PD at depths of
dmax, 5, and 10 cm for both 0◦ and 90◦ collimator rotations
and MLC shaped field are shown in Fig. 3 for both the 6 FFF
and 10 FFF beams. At a distance of 5 cm from the field
edge and a depth of 1.5 cm, the measured PD for the 6 FFF
beam was 1.31% versus 1.22% for the 0◦ and 90◦ collimator
rotations. At the same distance from the field edge and a
depth of 2 cm, the measured PD for the 10 FFF beam was
1.32% versus 1.15% for the 0◦ and 90◦ collimator rotations.
The PD measured at the nominal dmax at 10 cm from the
field edge was 0.36% versus 0.41% for the 6 FFF beam and
0.29% versus 0.36% for the 10 FFF beam for the 0◦ and
90◦ collimator rotations, respectively.
PD measurements for the 6 FFF beam were also compared
to the previously acquired PD measurements of a 6 MV beam
on a Varian Trilogy linac (Varian Medical Systems, Palo
Alto, CA).26 Figure 4 shows the measured PDs normalized
to the CAX at a depth of 1.5 cm for the 6 FFF and 6 MV
beams which were acquired at depths of 1.5, 5, 10 cm.
The PD measurements are shown for field sizes ranging
from 6× 6 to 30× 30 cm2, and distances of 5–40 cm from
the field edge with the MLC shaping the field apertures
and with a collimator rotation of 90◦. For larger field sizes
(20 × 20 to 30 × 30 cm2), the measured PD was smaller
for the 6 FFF beam compared to the 6 MV beam, 2.01%
compared to 2.57% for the 6 FFF and 6 MV photon beams,
respectively, at a distance of 5 cm from the field edge for
a 30× 30 cm2 square field. At a depth of 10 cm, the PDs
for the 6 FFF and 6 MV photon beams are nearly identical
for the 6× 6 and 10× 10 cm2 fields for all distances from
the field edge. Similar results were seen for the 15×15 cm2
field for all distances from the field edge except 5 cm, where
the measured PD is 2.51% compared to 2.96% for the 6
FFF and 6 MV beams, respectively. For the larger field sizes
(20×20 to 30×30 cm2), the measured PD was smaller for the
6 FFF beam compared to the 6 MV beam, 3.52% compared
to 5.56% for the 6 FFF and 6 MV photon beams, respectively,
at a distance of 5 cm from the field edge for a 30×30 cm2
square field.
Peripheral dose was also modeled in  (version 10)
by using both the AAA and Acuros dose calculation models.
Table III shows the percent error of the measured to calculated
PD for the 6 FFF and 10 FFF beams at 3×3 cm2 and 6×6 cm2
fields at depths of dmax, 5, and 10 cm. The difference in
measured versus calculated dose has not been normalized to
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T I. Percent ratio of the measured PD to the CAX dose at a depth of 1.5 cm for varying field sizes and depths
at distances ranging from 5 to 40 cm from the field edge for a 6 FFF photon beam.
Distance from the field edge (cm)
Field size Depth Collimator angle
(cm) (cm) MLC status (deg) 5 10 15 20 30 40
3 × 3 1.5 Shaped 90 0.16 0.06 0.03 0.02 0.01 0.01
3 × 3 5 Shaped 90 0.26 0.08 0.04 0.02 0.01 0.01
3 × 3 10 Shaped 90 0.37 0.11 0.05 0.02 0.01 0.01
6 × 6 1.5 Shaped 90 0.51 0.19 0.08 0.05 0.02 0.01
6 × 6 5 Shaped 90 0.74 0.25 0.11 0.05 0.02 0.01
6 × 6 10 Shaped 90 0.98 0.32 0.13 0.06 0.23 0.00
10 × 10 1.5 Retracted 0 1.31 0.65 0.41 0.23 0.09 0.04
10 × 10 5 Retracted 0 1.62 0.71 0.41 0.22 0.10 0.04
10 × 10 10 Retracted 0 1.98 0.79 0.42 0.22 0.09 0.04
10 × 10 1.5 Retracted 90 1.22 0.61 0.34 0.15 0.07 0.03
10 × 10 5 Retracted 90 1.56 0.69 0.37 0.17 0.07 0.03
10 × 10 10 Retracted 90 1.96 0.78 0.40 0.18 0.07 0.03
10 × 10 1.5 Shaped 0 0.96 0.36 0.18 0.10 0.04 0.02
10 × 10 5 Shaped 0 1.33 0.48 0.22 0.12 0.04 0.02
10 × 10 10 Shaped 0 1.75 0.61 0.27 0.14 0.04 0.02
10 × 10 1.5 Shaped 90 0.99 0.41 0.18 0.09 0.04 0.02
10 × 10 5 Shaped 90 1.36 0.52 0.23 0.11 0.04 0.02
10 × 10 10 Shaped 90 1.78 0.64 0.28 0.14 0.04 0.02
15 × 15 1.5 Shaped 90 1.45 0.63 0.31 0.16 0.05 0.03
15 × 15 5 Shaped 90 1.93 0.80 0.38 0.20 0.06 0.03
15 × 15 10 Shaped 90 2.51 0.99 0.45 0.23 0.07 0.03
20 × 20 1.5 Shaped 90 1.74 0.79 0.39 0.23 0.07 0.03
20 × 20 5 Shaped 90 2.32 1.01 0.49 0.27 0.09 0.03
20 × 20 10 Shaped 90 3.01 1.23 0.58 0.30 0.10 0.04
25 × 25 1.5 Shaped 90 1.89 0.88 0.44 0.25 0.10 0.04
25 × 25 5 Shaped 90 2.54 1.13 0.56 0.30 0.11 0.05
25 × 25 10 Shaped 90 3.31 1.39 0.67 0.35 0.12 0.05
30 × 30 1.5 Shaped 90 2.01 0.95 0.48 0.28 0.12 0.05
30 × 30 5 Shaped 90 2.69 1.22 0.61 0.34 0.13 0.06
30 × 30 10 Shaped 90 3.52 1.50 0.74 0.39 0.13 0.06
CAX dose and is therefore representative of the local rather
than the global error for AAA and Acuros. Between 5 and
10 cm from the field edge, the average percent error was found
to be 9% and 9.3% for AAA and Acuros, respectively, at all
energies and depths for 3× 3 cm2 and 6× 6 cm2 fields. For
the field sizes (3× 3 to 30× 30 cm2) evaluated, the average
percent error was −13.6% for AAA and −7.8% for Acuros for
all depths and distances of 5 and 10 cm from the field edge.
At distances from the field edge of 15 cm and greater, AAA
reported zero dose for all depths and field sizes. Acuros also
reported zero dose at distances from the field edge of ≥15 cm
for field sizes ≥10×10 cm2.
4. DISCUSSION
To demonstrate how this dataset can be implemented
clinically, the following simple example is provided. A pa-
tient with a pacemaker is scheduled to undergo radiotherapy
for a lung lesion with an average field size of 6× 6 cm2
and a 6 FFF beam. The prescription dose of 60 Gy is to
be delivered using a six-field treatment plan that includes
anterior–posterior (AP), posterior–anterior (PA), and four
oblique treatment beams. A detailed estimate of PD to the
pacemaker is requested by the treating physician. For each
field, the following methodology is applied: (1) the dose at
1.5 cm depth along the center of the field is found from
the treatment planning system, (2) the distance from the
beam edge to the most proximal portion of the pacemaker
is measured in the treatment planning system, (3) the depth
of the pacemaker from the body surface at the closest edge
of the treatment field is measured, and (4) the appropriate
figures or tables are used to estimate the out-of-field dose to
the device. Pacemaker depths less than 1.5 cm are treated as
though they were at 1.5 cm, while depths greater than 10 cm
are treated as though they were at 10 cm. These assumptions
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T II. Percent ratio of the measured PD to the CAX dose at a depth of 2 cm for varying field sizes and depths
at distances ranging from 5 to 40 cm from the field edge for a 10 FFF photon beam.
Distance from the field edge (cm)
Field size Depth Collimator angle
(cm) (cm) MLC status (deg) 5 10 15 20 30 40
3 × 3 2 Shaped 90 0.15 0.05 0.02 0.01 0.01 0.01
3 × 3 5 Shaped 90 0.18 0.06 0.03 0.01 0.01 0.01
3 × 3 10 Shaped 90 0.27 0.08 0.03 0.02 0.01 0.01
6 × 6 2 Shaped 90 0.48 0.17 0.07 0.03 0.02 0.00
6 × 6 5 Shaped 90 0.51 0.18 0.08 0.04 0.01 0.00
6 × 6 10 Shaped 90 0.71 0.23 0.09 0.04 0.02 0.00
10 × 10 2 Retracted 0 1.32 0.66 0.40 0.23 0.09 0.03
10 × 10 5 Retracted 0 1.17 0.54 0.33 0.18 0.08 0.03
10 × 10 10 Retracted 0 1.44 0.59 0.33 0.17 0.08 0.03
10 × 10 2 Retracted 90 1.15 0.55 0.32 0.14 0.06 0.03
10 × 10 5 Retracted 90 1.11 0.52 0.30 0.13 0.05 0.02
10 × 10 10 Retracted 90 1.41 0.58 0.31 0.13 0.05 0.02
10 × 10 2 Shaped 0 0.87 0.29 0.14 0.08 0.03 0.02
10 × 10 5 Shaped 0 0.90 0.32 0.15 0.08 0.03 0.02
10 × 10 10 Shaped 0 1.22 0.42 0.19 0.10 0.03 0.02
10 × 10 2 Shaped 90 0.90 0.36 0.15 0.08 0.03 0.01
10 × 10 5 Shaped 90 0.91 0.36 0.16 0.08 0.03 0.01
10 × 10 10 Shaped 90 1.24 0.45 0.20 0.10 0.03 0.01
15 × 15 2 Shaped 90 1.27 0.53 0.25 0.14 0.04 0.02
15 × 15 5 Shaped 90 1.26 0.53 0.26 0.14 0.04 0.02
15 × 15 10 Shaped 90 1.68 0.66 0.31 0.16 0.05 0.02
20 × 20 2 Shaped 90 1.49 0.64 0.31 0.18 0.06 0.03
20 × 20 5 Shaped 90 1.46 0.65 0.32 0.18 0.06 0.03
20 × 20 10 Shaped 90 1.95 0.80 0.38 0.20 0.07 0.03
25 × 25 2 Shaped 90 1.57 0.68 0.33 0.19 0.08 0.03
25 × 25 5 Shaped 90 1.56 0.71 0.36 0.20 0.08 0.03
25 × 25 10 Shaped 90 2.10 0.88 0.43 0.23 0.08 0.04
30 × 30 2 Shaped 90 1.63 0.72 0.35 0.21 0.09 0.04
30 × 30 5 Shaped 90 1.63 0.75 0.39 0.22 0.09 0.04
30 × 30 10 Shaped 90 2.18 0.93 0.46 0.25 0.09 0.05
are consistent with the references for the out-of-field dose
from flattened beams and provide a conservative estimate. As
an illustration, an estimate of PD is presented for only the
AP field of the six-field plan. The AP field size is 6×6 cm2
with a 90◦ collimator rotation delivering a dose of 15 Gy at a
1.5 cm depth along the center of the field. If the pacemaker is
5 cm from the field edge and at a 1.0 cm depth, Table I can
be used to estimate the out-of-field dose from the AP beam.
A PD of 0.51% is found from the first row of the 6×6 cm2
field data (indicating a 1.5 cm pacemaker depth) under the
column marked “5” (indicating a 5 cm distance from the
field edge). The total out-of-field dose from the AP field is
calculated as 15 Gy×0.0051= 7.7 cGy. Each of the fields can
be individually considered in this manner, the result summed,
and then reported to the requesting physician.
The PD for both the 6 FFF (see Table I) and 10
FFF (see Table II) photon beams were found to decrease
with increasing distance from the radiation field edge and
decreasing field size. Additionally, when comparing the PD
measurements for the 6 FFF and 10 FFF beams, the PD
was observed to decrease with increasing energy. Overall,
the measured PD was observed to be higher for the 6 FFF
than for the 10 FFF for all field sizes and depths. These
differences became more pronounced with increasing depth
and field sizes and for measurement distances closest to the
field edge. All PD values were acquired using static MLCs;
therefore, use caution when estimating PD for the modulated
fields.
When the field aperture was set by the collimator jaws
alone, the PD was observed to be moderately higher for a
0◦ collimator rotation relative to 90◦ for both the 6 FFF and
10 FFF photon beams. Conversely, when the field aperture
is shaped by the MLC, the PDs measured at 0◦ and 90◦ are
nearly identical for both the 6 FFF and 10 FFF beams with
the exception of measurements acquired at all depths for a
distance of 10 cm from the field edge. At this distance from
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F. 3. To evaluate the effects of collimator rotation (0◦—solid line and
90◦—dashed line) in the presence of the MLC, the measured PDs normalized
to the CAX dose at a depth of dmax are shown for (A) 6 FFF and (B) 10 FFF
photon beams at depths of dmax, 5, and 10 cm for both beam energies.
the field edge, the PD was observed to be slightly higher
with a 90◦ collimator rotation. For the Truebeam, a minimal
difference in PD was observed between the two collimator
rotation angles at distances between 5 and 30 cm from
the field edge which is consistent with the 6 MV flattened
beam results reported by Mutic and Klein.20 The impact of
collimator rotation on PD may be dependent on machine
make, model, and beam energy used; therefore, these results
should not be assumed to translate across all the machines.28
When comparing the measured PD for the 6 FFF and 6
MV flattened photon beams, the relative PD was found to
depend on the depth, field size, and distance from the field
edge (see Fig. 4). At a depth of 1.5 cm, the PD for the 6 FFF
beam was marginally higher than the 6 MV beam for the 6×6
and 10×10 cm2 field sizes up to a distance of 20 cm from the
field edge, measuring 0.51% versus 0.46% for the 6 FFF and
6 MV photon beams, respectively, for a 6×6 cm2 open field.
The PDs of the 6 FFF and 6 MV beam were nearly identical
for the 15×15 cm2 field size at all measured distances from
the field edge.
Since PD is a relative measurement, many uncertainties in
the data (e.g., calibration factor) do not impact the accuracy
of the values. Since the data were collected over several
weeks, the largest source of error is expected to be the
uncertainty of the setup relative to previous measurements.
To ameliorate this uncertainty, repeat measurements were
F. 4. Measured PDs normalized to the CAX dose at a depth of 1.5 cm for
the 6 FFF (solid line) and 6 MV (dashed line) beams acquired at depths of
(A) 1.5 cm, (B) 5 cm, and (C) 10 cm. The PD measurements are shown for
field sizes ranging from 6×6 to 30×30 cm2, and distances of 5–40 cm from
the field edge with the MLC shaping the field apertures and with a collimator
rotation of 90◦.
performed over the various data collection sessions to verify
reproducibility of the set-up as well as the stability of
equipment (e.g., ion chamber, electrometer). Please note, a
limitation of the current study is that a single measurement
was acquired for many data points due to the large number
of measurements (greater than 400) required to monitor the
PD trends. As such, standard deviations were unable to be
calculated. Repeat measurements were performed on a subset
of the data to address reproducibility. From nearly 30 repeat
measurements of various energies, field sizes, and distances
from the field edge, the average deviation from the initial
measurement was less than 4%. However, when PD is on
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T III. Percent error of measured PD to calculated PD for both the AAA and Acuros dose calculation models
for 3×3 and 6×6 cm2 fields.
% error from measurement
5 (cm) 10 (cm) 15 (cm)
Energy (MV) Field size (cm2) Depth (cm) AAA Acuros AAA Acuros AAA Acuros
6 FFF
3 × 3
1.5 −1.2 −6.1 −30.5 −13.6 — −68.8
5 3.8 −6.8 −13.4 −12.2 — −44.4
10 7.3 −5.7 −2.9 −12.4 — −32.6
6 × 6
1.5 −11.4 −12.4 −27.9 −6.3 — −28.0
5 1.9 −1.1 −13.7 −8.8 — −18.3
10 10.8 3.0 −4.4 −0.3 — −9.2
10 FFF
3 × 3
2 −10.0 −9.3 0.0 0.0 — −50.0
5 −8.2 −13.6 −19.6 −19.6 — −60.7
10 3.3 −8.4 −12.8 −26.9 — −30.3
6 × 6
2 −24.6 −12.4 −28.3 −7.8 — −33.3
5 −6.3 −9.6 −20.3 −19.8 — −28.6
10 2.7 −4.1 −9.3 −8.4 — −18.1
the order of 0.01% or less of the CAX dose, the uncertainty
is dominated by the resolution of the electrometer. Pion
for the ion chamber used was 1.012 at central axis under
calibration conditions for the 10 FFF beam. Compared to
a conventional flattened beam, this represents an approxi-
mately 0.7% increase in Pion that could indeed contribute
to the measured error when the values are normalized to
central axis. Combining this error in quadrature with setup
error results in a combined error of 4.1%; therefore, we have
conservatively added 5% error bars to all data points.
Similar to previous studies,18,25 the PD calculated using
both AAA and Acuros was typically found to underestimate
the dose when compared to the measured values. The differ-
ence in measured and calculated dose typically increased
as the distance from the field edge increased for both the
algorithms although exceptions were noted. For example,
the percent error in the TPS calculated dose for a 10 FFF
6×6 cm2 field at 5 cm from the field edge was −24.6%. The
percent error decreased to −7.8% at 10 cm from the field
edge. For small field sizes, where FFF beams are primarily
advantageous (e.g., SBRT and SRS), the underestimation
of the PD dose with AAA and Acuros was of a similar
magnitude.
Comparisons between the commercial algorithms and
measurements at distances greater than 10 cm from the field
edge were not performed, since AAA reports zero dose for
the designated points of interest that were beyond 10 cm
from the field edge. AAA uses a divergent dose matrix where
the width of the calculation matrix is dependent on the jaw
position. The default margin is 12 cm from the field but
can range for 7–12 cm to limit the number of calculation
points. Acuros uses the same margins for input fluences, but
extends the entire dose calculation to the entire calculation
volume [Varian Medical Systems (2014). Eclipse Photon and
Electron Reference Guide]. Even so, at distance of 15 cm
and greater, Acuros only reported calculated doses up to
field sizes of 10× 10 cm2. Acuros also underestimated the
PD at 15 cm from the field edge for both the 6 FFF and
10 FFF beams at field sizes of 3×3 and 6×6 cm2 with an
average percent error of −35%. The maximum percent error
(−68.8%) was observed with a 6 FFF energy at 15 cm from
a 3×3 cm2 field at 1.5 cm depth. This level of uncertainty in
calculated dose has clinical significance for estimating dose
to out-of-field organs at risk (OARs). For example, when
estimating the dose to a fetus using a 3× 3 cm2 field at
1.5 cm depth and 15 cm from the field edge, Acuros reports
PD of 0.01%. For a 50 Gy treatment, the estimated dose to
the fetus is 5 mGy. When using Table I, PD was measured
to 0.03% and the estimated dose would be 15 mGy. The
average percent error from the measured PD compared to
Acuros for field sizes 3×3, 6×6, and 10×10 cm2 at 15 cm
from the field edge was −29%. It is highly recommended
that TPS calculated PD should be verified by measurement
when making critical clinical decisions on out-of-field OARs
during treatment planning.
The Varian TrueBeam representative beam data used for
the models incorporate profiles that typically extend 5 cm
beyond the nominal field edge. This dataset was selected
because it is widely available and frequently encountered in
the clinical setting. It may be possible to improve agreement
with measured doses by using a commissioning dataset that
extends further outside of the field edge and developing a
beam model that uses parameters optimized for extrafocal
radiation components. The manufacturer (Varian Medical
Systems, Palo Alto, CA) was not able to clarify how much
improvement could be expected if such an approach was
used.
Neutron dose is also of concern when considering periph-
eral dose to electronic implantable devices, pediatric patients
or fetus. The energies used in this paper do not exceed
10 MV; therefore, neutron dose is not expected contribute
significantly to PD. In FFF beams, the absence of the
flattening filter and reduced photon fluence are expected to
reduce neutron contamination. We refer readers to the AAPM
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report on FFF beams for a detailed discussion on FFF beams
and neutron dose.10
5. CONCLUSIONS
PD was measured for various field sizes (3× 3 to 30
× 30 cm2) and distances from field edge (5–20 cm) for the
6 FFF and 10 FFF beams in a solid water phantom. This
comprehensive dataset can be used to estimate PD to out-
of-field regions of interest such as organs at risk, electronic
implantable devices, and the fetus. Peripheral dose was
found to decrease with increasing energy and increase with
increasing depth in the phantom. The impact of collimator
rotation (0◦ versus 90◦) was found to slightly decrease PD;
however, when combined with tertiary MLCs, the impact of
collimator rotation was not clinically significant. Peripheral
dose was calculated in a commercial treatment planning
system by using both AAA and Acuros dose calculation
algorithms. Both algorithms underestimated the PD, and the
percent error between measured and calculated PD varied
with field size and distance from the field edge; therefore,
physicists should use caution when interpreting and applying
TPS calculated PD to determine dose to critical structures.
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